Drop in Breast Cancer Death Rates May Not Be Linked to
FRIDAY, July 29 (HealthDay News) -- Developed countries have
seen a drop in breast cancer death rates in recent years, but a new
international study suggests this trend is less about rising
screening rates and more about the availability of increasingly
effective treatments and improving health-care systems.
The finding stems from an analysis of World Health Organization
(WHO) breast cancer data collected between 1980 and 2006, in which
French, British and Norwegian researchers compared the screening
and fatality rates of several Western European countries. The
observations were presented online July 29 in the
British Medical Journal.
"The contrast between the time differences in implementation of mammography screening and the similarity in reductions in mortality between the country pairs suggest that screening did not play a direct part in the reductions in breast cancer mortality," a team of researchers led by Philippe Autier, research director of the International Prevention Research Institute in Lyon, France, said in a journal news release.
To explore to what degree breast cancer screening rates appeared
to be related to fatality rates, the authors chose six countries
for points of comparison.
Northern Ireland was stacked up against the Republic of Ireland;
the Netherlands was compared with Belgium/Flanders; and Sweden was
examined alongside Norway.
The team noted that medical services and the prevalence of
breast cancer death risk factors were comparable in each pairing.
However, in the space of the study, the second country of each of
the three groups was 10 to 15 years behind the first country in
terms of their implementation of mammography screening
The results: Breast cancer death rates, which dropped across the
board, were more or less similar in each country pairing, despite
stark differences in screening histories.
For example, fatalities between 1989 and 2006 had plummeted by
29 percent in Northern Ireland, as compared with 26 percent in the
Republic of Ireland.
The Netherlands registered a 25 percent drop, compared with a 20
percent to 25 percent drop in Belgium/Flanders, while the downward
trend of 16 percent in Sweden compared with 24 percent in
In general terms, Autier's team also noted breast cancer death
rates were not that different among women who had undergone almost
no screening as compared with those who had been screened quite
And the biggest death rate drop seen overall was among women
between the ages of 40 and 49, whether or not they had undergone
Dr. Lauren Cassell, chief of breast surgery at Lenox Hill
Hospital (affiliated with Northshore/LIJ) in New York City,
cautioned that it's not clear that the current findings are easily
generalizable to other nations.
"I'm not sure how well this finding would translate in comparison with the U.S.," she noted. "I suspect that we may be more aggressive in our screening protocols, and our health system is very different from the ones they looked at."
"And, in any case, I would certainly say that people should continue getting screened," Cassell stressed. "Because we still do know that catching any cancer at an earlier stage does translate into better outcomes and maybe less treatment. Because even if the end result is the same, and fatal, I certainly would like to have a cancer that could be treated with hormonal treatment and not chemotherapy, if possible."
For more on breast cancer screening guidelines in the United
States, visit the
American Cancer Society.
Copyright © 2011
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.